Immunohistochemical localisation of RET and p53 mutant protein of thyroid lesions in a North‐Eastern Malaysian population and its prognostic implications

References

• Preston-Martin S, Brenstein L, Pike MC. Thyroid cancer among young women related to prior thyroid disease and pregnancy history. Br J Cancer 1987; 55: 191–252.
   Google Scholar
• Madhavan M, Nor Hayati 0. Spectrum of thyroid diseases in Hospital Universiti Sains Malaysia: a study of 300 consecutive cases. Malays J Med Sci 1996; 3(2): 58 (abstract).
   Google Scholar
• Murray D. The thyroid gland. In: Kovacs K, Asa SL, editors. Functional Endocrine Pathology. 2nd ed. Ottawa: Blackwell Science, 1998; 295–380.
   Google Scholar
• Fagin JA. Molecular pathogenesis of carcinoma of follicular epithelium. In: Braverman LE, Utiger RD, editors. Werner's and Ingbar's The Thyroid. 8th ed. Boston: Lippincott Williams & Wilkins, 2000; 886–98.
   Google Scholar
• Santoro M, Carlomagno F, Hay ID, et al. Ret oncogene activation in human thyroid neoplasms is restricted to the papillary cancer subtypes. J Clin Invest 1992; 89: 1517–22.
   PubMed Web of Science ®Google Scholar
• Jhiang SM, Mazzaferri EL. The ret/PTC oncogene in papillary thyroid carcinoma. J Clin Invest 1994; 123: 331–7.
   Google Scholar
• Grieco M, Santoro M, Berligieri MT, et al. PTC is a novel rearranged form of the RET proto-oncogene and is frequently detected in vivo in human papillary thyroid carcinoma. Cell 1990; 60: 557–63.
   PubMed Web of Science ®Google Scholar
• Ceccherini I, Bocciardi R, Yin L, et al. Exon structure and flanking intronic sequences of the human ret protooncogene. Biochem Biophys Res Commun 1993; 2: 247–52.
   Google Scholar
• Gardener E, Pappi L, Easton DF. Genetic linkage studies map the multiple endocrine neoplasia type 2 loci to a small interval on chromosome 10q11.2. Hum Mol Genet 1993; 2: 241–6.
   Google Scholar
• Kwok JBJ, Gardener E, Werner JP, Ponder BAJ, Mulligan LM. Structural analysis of the RET proto-oncogene using exon trapping. Oncogene 1993; 8: 2575–82.
   Google Scholar
• Fusco A, Grieco M, Santoro M, et al. A new oncogene in human papillary thyroid carcinomas and their lymph nodal metastases. Nature 1987; 328: 170–2.
   PubMed Web of Science ®Google Scholar
• Bonzargone I, Monzini N, Borrello MG, et al. Molecular character-ization of a thyroid tumour-specific transforming sequence formed by the fusion of RET tyrosine-kinase and the regulatory sub-unit RI alpha of cyclic AMP protein kinase A. Mol Cell Biol 1993; 13: 358–66.
   PubMed Web of Science ®Google Scholar
• Santoro M, Dathan NA, Berfigiery MT, et al. Molecular characterization of RET/PTC-3: a novel rearranged version of the RET proto-oncogene in a human papillary thyroid carcinoma. Oncogene 1994; 9: 506–16.
   Web of Science ®Google Scholar
• Hosal SA, Apel RL, Freeman JL, et al. Immunohistochemical localization of p53 in human thyroid neoplasms: correlation with biologic behavior. Endocr Pathol 1997; 8(1): 21–8.
   PubMed Web of Science ®Google Scholar
• Mayr B, Potter E, Goretzki P, et al. Expression of wild type ret, ret/ PTC and ret/PTC variants in papillary thyroid carcinoma in Germany. Langenbecks Arch Surg 1999; 384: 54–9.
   PubMed Web of Science ®Google Scholar
• Norton JA. Endocrine tumours. In: Pollock RE, Doroshaw JS, Geraghty JG, Khayat D, Kim JP, O'Sullivan B, editors. UICC International Union Against Cancer Manual of Clinical Oncology. 7th ed. New York: Wiley-Liss, 1999; 359–84.
   Google Scholar
• Miller BA, Kolonel LN, Bernstein L, et al., editors. Racial/Ethnic Patterns of Cancer in the United States 1988–1992. National Cancer Institute, 1996.
   Google Scholar
• Ballivet S, Salmi LR, Dubordieu D, Bach F. Incidence of thyroid cancer in New Caledonia, South Pacific, during 1985-1992. Am J Epidemiol 1995; 141: 741–6.
   PubMed Web of Science ®Google Scholar
• Tallini G, Asa SL. RET oncogene activation in papillary thyroid carcinoma. Adv Anat Pathol 2001; 8: 345–54.
   PubMed Web of Science ®Google Scholar
• Tallini G, Santoro M, Helie M, et al. RET/PTC oncogene activation defines a subset of papillary thyroid carcinoma lacking progression to poorly differentiated or undifferentiated tumour phenotypes. Clin Cancer Res 1998; 4: 287–94.
   PubMed Web of Science ®Google Scholar
• Sugg SL, Ezzat S, Rosen TB, Freeman JL, Asa SL. Distinct Multiple RET/PTC gene rearrangements in multifocal papillary thyroid neopalsia. J Clin Endocrinol Metab 1998; 83: 4116–22.
   Google Scholar
• Soravia C, Sugg SL, Berk T, et al. Familial adenomatous polyposis-associated thyroid cancer: a clinical, pathological and molecular genetics study. Am J Pathol 1999; 154: 127–35.
   PubMed Web of Science ®Google Scholar
• Cheung CC, Carydis B, Ezzat S, Bedard YC, Asa SL. The analysis of ret/PTC rearrangements refines the fine needle aspiration of thyroid carcinoma. J Clin Endocrinol Metab 2001; 86: 2187–90.
   Google Scholar
• Cheung CC, Ezzat S, Freeman JL, Rosen TB, Asa SL. Immuno-histochemical diagnosis of papillary thyroid carcinoma. Mod Pathol 2001; 14(4): 338–42.
   Google Scholar
• Ishizaka Y, Kobayashi S, Ushijama T, Hirohashi S, Sugimura T, Nagao M. Detection of ret/PTC transcriptions in thyroid adenomas and adenomatous goiter by an RT-PCR method. Oncogene 1991; 6: 1667–72.
   PubMed Web of Science ®Google Scholar
• Cinti R, Yin L, Ilc K, et al. Ret rearrangements in papillary thyroid carcinomas and adenomas detected by interphase FISH. Cytogenet Cell Genet 1999; 88: 56–61.
   Google Scholar
• Park KY, Koh JM, Kim YT, et al. Prevalence of Gs alpha, ras, p53 mutations and ret/PTC arrangement in differentiated thyroid tumours in a Korean population. Clin Endocrinol (Oxf) 1998; 49(3): 317–23.
   PubMed Web of Science ®Google Scholar
• Chung JH, Hahm JR, Min YK, et al. Detection of RET/PTC oncogene rearrangement in Korean papillary thyroid papillary thyroid carcinomas. Thyroid 1999; 9(12): 1237–43.
   PubMed Web of Science ®Google Scholar
• Martinez I, Mantilla A, Medrano ME, et al. High prevalence of RET tyrosine kinase activation in Mexican patients with papillary thyroid carcinomas. Endocrinol Pathol 2001; 12(2): 113–23.
   PubMed Web of Science ®Google Scholar
• Chua EL, Wu WM, Tran KT, et al. Prevalence and distribution of ret/ ptc 1,2 and 3 in papillary thyroid carcinoma in New Caledonian and Australia. J Clin Endocrinol Metab 2000; 85: 2733–9.
   PubMed Web of Science ®Google Scholar
• Basolo F, Molinaro E, Agate L, et al. RET protein expression has no prognostic impact on the long-term outcome of papillary thyroid carcinoma. Eur J Endocrinol 2001; 145(5): 599–604.
   PubMed Web of Science ®Google Scholar
• Musholt Ti, Musholt PB, Khaladj N, Schultz D, Scheumann GFW, Klempnauer J. Prognostic significance of RET and NTRK1 rearrangements in sporadic papillary thyroid carcinoma. Surgery 2000; 128: 984–93.
   PubMed Web of Science ®Google Scholar
• Goretzki PE, Dotzenrath C, Simon D, Roher H-D. Studies of oncogenes and tumour suppressor genes in human thyroid carcino-mas, and their clinical implications. Langenbecks Arch Surg 1999; 384(1): 1–8.
   Google Scholar
• Godballe C, Aschenfeldt P, Jorgensen KE, et al. Prognostic factors in papillary and follicular thyroid carcinomas: p53 expression is a significant indicator of prognosis. Laryngoscope 1998; 108: 243–9.
   PubMed Web of Science ®Google Scholar
• La Perle KM, Jhiang SM, Capen CC. Loss of p53 promotes anaplasia and local invasion in ret/PTC induced thyroid carcinomas. Am J Pathol 2000; 152: 671–7.
   Google Scholar
• Cetta F, Chiapetta G, Melillo RM, et al. The RET/PTC oncogene is activated in familial adenomatous polyposis associated thyroid papillary carcinoma. J Clin Endocrinol Metab 1998; 83: 1003–6.
   PubMed Web of Science ®Google Scholar
• Wajjwalku W, Nakamura S, Hasegawa Y, et al. Low frequency of the ret and trk proto-oncogenes in Japanese thyroid papillary carcinomas. Jpn J Cancer Res 1992; 83: 671–5.
   PubMedGoogle Scholar
• Zou M, Shi Y, Farid NR. Low rate of ret proto-oncogene activation (PTC/ret Tin in papillary thyroid carcinomas from Saudi Arabia. Cancer 1994; 73: 176–80.
   Google Scholar
• Sugg SL, Zheng L, Rosen TB, Freeman JL, Ezzat S, Asa SL. Ret/ PTC-1, -2, and -3 oncogene rearrangements in human papillary thyroid carcinomas: implication for metastatic potential? J Clin Endocrinol Metab 1996; 81: 3360–5.
   PubMed Web of Science ®Google Scholar
• Mayr B, Potter E, Goretzki P, et al. Expression of Ret/PTC-1, -2, -delta3 and-4 in German papillary thyroid carcinoma. Br J Cancer 1998; 77: 903–6.
   PubMed Web of Science ®Google Scholar
• Klugbaeuer S, Lengfelder E, Demidchick EP, Rabes HM. Molecular analysis of new subtypes of ELE/RET rearrangement, their reciprocal transcripts and break points in papillary thyroid carcinomas of children after Chernobyl. Oncogene 1998; 16: 671–5.
   PubMed Web of Science ®Google Scholar
• Motumura T, Nikirov YE, Namba H, et al. RET rearrangements in Japanese pediatric and adult papillary thyroid cancers. Thyroid 1998; 8: 485–9.
   PubMed Web of Science ®Google Scholar
• Lee CH, Hsu LS, Chi CW, Chen GD, Yang AH, Chen JY. High frequency of rearrangement of the ret proto-oncogene in Chinese papillary carcinoma. J Clin Endocrinol Metab 1998; 83: 2006–9.
   PubMed Web of Science ®Google Scholar